← Back to the feed
Earnings4526RIKEN VITAMIN CO.,LTD.

Riken Vitamin Reports Q1 Revenue of 25.1 billion, Up 8%

– Riken Vitamin Co., Ltd. (4526.T) reported consolidated results for Q1 FY2027 (ending March 2027).

Revenue was ¥25.1 billion (+8.1% YoY). operating profit was ¥2,248 million (-4.9%). net profit attributable to shareholders was ¥1,869 million (+2.4%).

Total assets stood at ¥120 billion with an equity ratio of 71.9%. The company declared an annual dividend of ¥55 per share. The full-year forecast for the current fiscal year is revenue of ¥100 billion (+3.8%).

Financial results — FY2027/3 (consolidated)

MetricCurrentYoY
Revenue¥25,133M+8.1%
Operating profit¥2,248M-4.9%
Net profit¥1,869M+2.4%

Next period forecast

Revenue

¥100,000M

+3.8%

Op. profit

¥7,100M

+2.9%

Net profit

¥7,500M

+6.6%

Figures in millions of yen

PDFOriginal disclosure16:00 JSTView original ↗
End of article